BerandaRGEN • NASDAQ
add
Repligen Corp
Tutup sebelumnya
$162,02
Rentang hari
$157,29 - $164,30
Rentang tahun
$102,97 - $182,06
Kapitalisasi pasar
9,16Â M USD
Volume Rata-Rata
602,87Â rb
Rasio P/E
6.363,69
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 188,80Â jt | 21,91% |
Biaya operasional | 87,84Â jt | 5,00% |
Penghasilan bersih | 14,91Â jt | 2.379,97% |
Margin laba bersih | 7,90 | 1.980,95% |
Penghasilan per saham | 0,46 | 6,98% |
EBITDA | 32,69Â jt | 156,90% |
Tarif pajak efektif | 12,86% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 748,75Â jt | -4,49% |
Total aset | 2,92Â M | 3,29% |
Total liabilitas | 840,62Â jt | 3,28% |
Total ekuitas | 2,08 M | — |
Saham yang beredar | 56,29 jt | — |
Harga terhadap nilai buku | 4,38 | — |
Tingkat pengembalian aset | 1,09% | — |
Tingkat pengembalian modal | 1,15% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 14,91Â jt | 2.379,97% |
Kas dari operasi | 48,10Â jt | -2,48% |
Kas dari investasi | -7,78Â jt | -32,84% |
Kas dari pembiayaan | -239,00Â rb | 99,66% |
Perubahan kas bersih | 39,89Â jt | 258,41% |
Arus kas bebas | 41,60Â jt | 9,85% |
Tentang
Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide. Wikipedia
CEO
Didirikan
1981
Kantor pusat
Situs
Karyawan
1.778
